Institutional Ownership
Aquestive Therapeutics Inc
CUSIP 03843E104COMAQSTQ1 2026
13D / 13G Filings
15
Schedule 13D/13G on record
Beneficial Filers
7
Distinct reporting persons
Largest Stake
16.1%
Max % of class reported
Institutional Holders
178
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
15 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Rtw Investments, LP | 13G | 5.2% | 6.25M | SEC |
| 2 | Oct 17, 2025 | Blackrock, Inc. | 13G/A | 5.3% | 6.43M | SEC |
| 3 | Feb 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 2.9% | 2.63M | SEC |
| 4 | Feb 13, 2025 | Bratton Douglas K | 13G/A | 11.1% | 10.08M | SEC |
| 5 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 2.9% | 2.75M | SEC |
| 6 | Nov 8, 2024 | Blackrock, Inc. | 13G | 6.4% | 5.82M | SEC |
| 7 | Oct 22, 2024 | Blackrock, Inc. | 13G | 6.4% | 5.82M | SEC |
| 8 | Apr 1, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G | 6.5% | 5.56M | SEC |
| 9 | Feb 14, 2024 | Armistice Capital, LLC | 13G | 5.9% | 3.92M | SEC |
| 10 | Feb 11, 2022 | Bratton Douglas K | 13G/A | 8.6% | 3.47M | SEC |
5 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Aquestive Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bratton Capital Management, L.P. | 9.81M | $40.72M |
| 2 | Blackrock, Inc. | 7.51M | $31.16M |
| 3 | Rtw Investments, LP | 7.43M | $30.82M |
| 4 | Vanguard Capital Management LLC | 4.44M | $18.44M |
| 5 | Federated Hermes, Inc. | 2.94M | $12.20M |
| 6 | Balyasny Asset Management L.P. | 2.90M | $12.04M |
| 7 | State Street Corp | 2.55M | $10.57M |
| 8 | Samsara Biocapital, LLC | 2.50M | $10.38M |
| 9 | Geode Capital Management, LLC | 2.41M | $10.00M |
| 10 | Bank Of America Corp /De/ | 2.41M | $9.98M |